Santhera Pharmaceuticals Holding AG (SPHDF)
USD 17.01
(5.0%)
USD 17.01
(5.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 130.21 Million USD | 88.95% |
| 2022 | 68.91 Million USD | -31.0% |
| 2021 | 99.87 Million USD | -0.46% |
| 2020 | 100.33 Million USD | -15.55% |
| 2019 | 118.81 Million USD | 6.19% |
| 2018 | 111.88 Million USD | -0.68% |
| 2017 | 112.65 Million USD | 26.11% |
| 2016 | 89.33 Million USD | -23.67% |
| 2015 | 117.03 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 120.49 Million USD | 0.4% |
| 2024 Q1 | 120.02 Million USD | -7.82% |
| 2023 Q1 | 68.95 Million USD | 0.05% |
| 2023 FY | 130.21 Million USD | 88.95% |
| 2023 Q4 | 130.21 Million USD | 8.72% |
| 2023 Q3 | 119.76 Million USD | 70.03% |
| 2023 Q2 | 70.43 Million USD | 2.15% |
| 2022 Q2 | 83.43 Million USD | 0.0% |
| 2022 FY | 68.91 Million USD | -31.0% |
| 2022 Q4 | 68.91 Million USD | 6.7% |
| 2022 Q3 | 64.58 Million USD | -22.59% |
| 2021 Q2 | 86.78 Million USD | 0.0% |
| 2021 FY | 99.87 Million USD | -0.46% |
| 2021 Q4 | 99.87 Million USD | 0.0% |
| 2020 FY | 100.33 Million USD | -15.55% |
| 2020 Q4 | 100.33 Million USD | 0.0% |
| 2020 Q2 | 105.61 Million USD | 0.0% |
| 2019 Q2 | 108.81 Million USD | 0.0% |
| 2019 FY | 118.81 Million USD | 6.19% |
| 2019 Q4 | 118.81 Million USD | 0.0% |
| 2018 FY | 111.88 Million USD | -0.68% |
| 2017 FY | 112.65 Million USD | 26.11% |
| 2016 FY | 89.33 Million USD | -23.67% |
| 2015 FY | 117.03 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 2310.00 USD | -5636728.918% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -6549.55% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -1133.757% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -23483.777% |
| Rebus Holdings, Inc. | 5000.00 USD | -2604114.96% |
| Qrons Inc. | 420.00 USD | -31002459.048% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -16796.355% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -365.97% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -26995.797% |
| Skye Bioscience, Inc. | 11.94 Million USD | -990.505% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -235.189% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -1703.532% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -170435.595% |
| SQZ Biotechnologies Company | 107.18 Million USD | -21.48% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -8992.726% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -179836.085% |
| Mesoblast Limited | 667.9 Million USD | 80.504% |
| Marizyme, Inc. | 22.01 Million USD | -491.462% |
| Genus plc | 1.02 Billion USD | 87.345% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -9485.929% |
| Pharming Group N.V. | 462.85 Million USD | 71.868% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -3830.283% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -25992.299% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -20667.264% |
| ContraFect Corporation | 20.67 Million USD | -529.676% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -33256.068% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -33970.797% |
| IMV Inc. | 31.33 Million USD | -315.56% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -3040.619% |
| MultiCell Technologies, Inc. | 126.22 USD | -103161639.819% |
| ONE Bio Corp. | 70.08 Million USD | -85.788% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -13756.792% |
| RVL Pharmaceuticals plc | 128.51 Million USD | -1.323% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -30061.345% |
| Q BioMed Inc. | 3.51 Million USD | -3603.886% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -270.138% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -49736.284% |
| Biomind Labs Inc. | 73.81 Thousand USD | -176291.915% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 70.825% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -8887.223% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -333.82% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -4641.255% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -18840.131% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -4901.957% |
| GB Sciences, Inc. | 103.44 Thousand USD | -125778.026% |
| Alpha Cognition Inc. | 2.45 Million USD | -5210.021% |
| HST Global, Inc. | 1526.00 USD | -8532714.417% |
| CSL Limited | 38.02 Billion USD | 99.658% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -13079.666% |
| Halberd Corporation | 10.13 Thousand USD | -1285170.437% |
| Enzolytics Inc. | 361.7 Million USD | 64.001% |
| Agentix Corp. | 261.39 Thousand USD | -49714.359% |
| Resverlogix Corp. | 8.11 Million USD | -1504.569% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -6833.923% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 97.133% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -172.967% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -20256.371% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -571476.085% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -1355.006% |
| AVAX Technologies, Inc. | 7.37 Million USD | -1665.053% |
| Zenith Capital Corp. | 7410.00 USD | -1757130.067% |
| Genscript Biotech Corporation | 3.38 Billion USD | 96.155% |
| Ember Therapeutics, Inc. | 184.00 USD | -70766610.87% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -40362.499% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -49719.695% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -13931.92% |
| Kadimastem Ltd | 2.3 Million USD | -5551.312% |
| Helix BioMedix, Inc. | 3.02 Million USD | -4204.365% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -147.075% |
| BioStem Technologies, Inc. | 14.56 Million USD | -794.287% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -227963.804% |
| LadRx Corporation | 2.3 Million USD | -5542.002% |
| Cell Source, Inc. | 195.17 Thousand USD | -66616.238% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -36722.536% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -36722.536% |
| NovAccess Global Inc. | 62.24 Thousand USD | -209080.613% |
| Affymax, Inc. | 7.44 Million USD | -1649.439% |
| Itoco Inc. | 1.4 Million USD | -9200.289% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -136022.55% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -122740.328% |
| Mobile Lads Corp. | 52.00 USD | -250405184.615% |
| CytoDyn Inc. | 11.13 Million USD | -1069.278% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -90974.3% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -728148.031% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -33679.648% |
| SYBLEU INC | 330.46 Thousand USD | -39301.923% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -31703.554% |
| International Stem Cell Corporation | 5.39 Million USD | -2315.784% |
| Bioxytran, Inc. | 137.63 Thousand USD | -94503.778% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -767.966% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -685.396% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -164723.732% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -14958.889% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -1632.217% |
| Neutra Corp. | 2851.00 USD | -4567095.651% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -301.811% |
| PureTech Health plc | 693.97 Million USD | 81.237% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -1513.298% |
| IXICO plc | 15.84 Million USD | -721.835% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -1472.214% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -26.022% |
| CSL Limited | 38.02 Billion USD | 99.658% |
| Cellectis S.A. | 333.99 Million USD | 61.014% |